Long Term Oral Etoposide As Second-Line Therapy In Recurrent Epithelial Carcinoma Of The Ovary

Background: The activity and toxicity of etoposide in women with recurrent ovarian cancer was evaluated in a case series of women with recurrent ovarian cancer who had measurable disease, Methods: All patients had plior platinum-based chemotherapy and developed progressive disease, Etoposide was giv...

Full description

Bibliographic Details
Main Authors: Azam Sadat Moosavi, Afsaneh Tehranian, Nadereh Behtash, Mitra Modares Gilani, Fatemeh Ghaem-Maghami
Format: Article
Language:English
Published: Iran University of Medical Sciences 2005-01-01
Series:Medical Journal of The Islamic Republic of Iran
Subjects:
Online Access:http://mjiri.tums.ac.ir/browse.php?a_id=1602&slc_lang=en&sid=1&ftxt=1